Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
Mimedx Group Inc (NASDAQ: MDXG) closed the day trading at $6.51 up 2.36% from the previous closing price of $6.36. In other words, the price has increased by $2.36 from its previous closing price. On the day, 0.75 million shares were traded. MDXG stock price reached its highest trading level at $6.575 during the session, while it also had its lowest trading level at $6.3.
Ratios:
For a better understanding of MDXG, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 11.67 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 38.59. For the most recent quarter (mrq), Quick Ratio is recorded 3.11 and its Current Ratio is at 3.57. In the meantime, Its Debt-to-Equity ratio is 0.35 whereas as Long-Term Debt/Eq ratio is at 0.34.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Lake Street on March 07, 2024, initiated with a Buy rating and assigned the stock a target price of $12.
On October 27, 2023, Craig Hallum started tracking the stock assigning a Buy rating and target price of $12.
On October 13, 2022, Mizuho started tracking the stock assigning a Buy rating and target price of $7.Mizuho initiated its Buy rating on October 13, 2022, with a $7 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 13 ’24 when Hulse William Frank IV sold 20,381 shares for $7.95 per share. The transaction valued at 162,029 led to the insider holds 479,959 shares of the business.
Whitlow Ricci S sold 15,271 shares of MDXG for $122,351 on Feb 20 ’24. The Chief Operating Officer now owns 401,050 shares after completing the transaction at $8.01 per share. On Feb 16 ’24, another insider, Whitlow Ricci S, who serves as the Chief Operating Officer of the company, sold 15,493 shares for $8.07 each. As a result, the insider received 125,075 and left with 416,321 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MDXG now has a Market Capitalization of 960765440 and an Enterprise Value of 903200576. As of this moment, Mimedx’s Price-to-Earnings (P/E) ratio for their current fiscal year is 18.90, and their Forward P/E ratio for the next fiscal year is 15.14. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.26. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.98 while its Price-to-Book (P/B) ratio in mrq is 6.67. Its current Enterprise Value per Revenue stands at 2.81 whereas that against EBITDA is 22.278.
Stock Price History:
Over the past 52 weeks, MDXG has reached a high of $9.27, while it has fallen to a 52-week low of $3.49. The 50-Day Moving Average of the stock is -14.49%, while the 200-Day Moving Average is calculated to be -13.66%.
Shares Statistics:
Over the past 3-months, MDXG traded about 788.60K shares per day on average, while over the past 10 days, MDXG traded about 700650 shares per day. A total of 146.23M shares are outstanding, with a floating share count of 112.98M. Insiders hold about 23.12% of the company’s shares, while institutions hold 41.73% stake in the company. Shares short for MDXG as of 1711584000 were 5175898 with a Short Ratio of 6.56, compared to 1709164800 on 5295181. Therefore, it implies a Short% of Shares Outstanding of 5175898 and a Short% of Float of 3.55.
